Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
First Solar
FSLR
|
+$24.3M |
| 2 |
Lamb Weston
LW
|
+$21.6M |
| 3 |
Ovintiv
OVV
|
+$21.3M |
| 4 |
Hubbell
HUBB
|
+$21.3M |
| 5 |
U-Haul Holding Co Series N
UHAL.B
|
+$19.6M |
Top Sells
| 1 |
Apple
AAPL
|
+$627M |
| 2 |
Microsoft
MSFT
|
+$479M |
| 3 |
Amazon
AMZN
|
+$203M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$169M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$150M |
Sector Composition
| 1 | Technology | 25.32% |
| 2 | Healthcare | 16.62% |
| 3 | Consumer Discretionary | 10.98% |
| 4 | Industrials | 9.74% |
| 5 | Consumer Staples | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATRI
1926
DELISTED
Atrion Corp
ATRI
| $1.9M | ﹤0.01% |
3,402
| – | – |
|
1927
Origin Bancorp
OBK
$1.11B
| $1.9M | ﹤0.01% |
51,682
+1,000
| +2% | +$36.7K |
|
1928
Enact Holdings
ACT
$5.76B
| $1.9M | ﹤0.01% |
78,600
+1,900
| +2% | +$45.8K |
|
|
ORLA
1929
Orla Mining
ORLA
$3.76B
| $1.89M | ﹤0.01% |
468,300
| – | – |
|
1930
Ambac
AMBC
$412M
| $1.89M | ﹤0.01% |
108,500
+1,700
| +2% | +$29.6K |
|
1931
Fate Therapeutics
FATE
$112M
| $1.89M | ﹤0.01% |
187,400
+4,100
| +2% | +$41.4K |
|
1932
James River Group
JRVR
$244M
| $1.89M | ﹤0.01% |
90,399
+1,600
| +2% | +$33.5K |
|
1933
International Money Express
IMXI
$431M
| $1.88M | ﹤0.01% |
77,300
| – | – |
|
|
AHH
1934
Armada Hoffler Properties
AHH
$597M
| $1.88M | ﹤0.01% |
163,600
+3,000
| +2% | +$34.5K |
|
1935
RCI Hospitality Holdings
RICK
$302M
| $1.87M | ﹤0.01% |
20,100
+1,100
| +6% | +$103K |
|
|
INN
1936
Summit Hotel Properties
INN
$622M
| $1.86M | ﹤0.01% |
258,100
+6,300
| +3% | +$45.5K |
|
1937
Jamf
JAMF
$1.37B
| $1.86M | ﹤0.01% |
87,400
+2,200
| +3% | +$46.9K |
|
1938
Ichor Holdings
ICHR
$582M
| $1.86M | ﹤0.01% |
69,400
+1,500
| +2% | +$40.2K |
|
|
ZUO
1939
DELISTED
Zuora, Inc.
ZUO
| $1.86M | ﹤0.01% |
292,600
+5,400
| +2% | +$34.3K |
|
1940
Titan International
TWI
$557M
| $1.86M | ﹤0.01% |
121,400
+2,500
| +2% | +$38.3K |
|
|
PLYM
1941
Plymouth Industrial REIT
PLYM
$982M
| $1.86M | ﹤0.01% |
96,900
+1,800
| +2% | +$34.5K |
|
1942
Janus International
JBI
$1.43B
| $1.85M | ﹤0.01% |
194,800
+4,900
| +3% | +$46.6K |
|
1943
Univest Financial
UVSP
$889M
| $1.85M | ﹤0.01% |
70,878
+1,200
| +2% | +$31.4K |
|
1944
Hims & Hers Health
HIMS
$12.3B
| $1.85M | ﹤0.01% |
287,900
+6,600
| +2% | +$42.3K |
|
1945
Adaptive Biotechnologies
ADPT
$1.95B
| $1.85M | ﹤0.01% |
241,500
+5,400
| +2% | +$41.3K |
|
1946
Green Dot
GDOT
$752M
| $1.84M | ﹤0.01% |
116,300
| – | – |
|
1947
Bank First Corp
BFC
$1.26B
| $1.84M | ﹤0.01% |
19,817
+400
| +2% | +$37.1K |
|
1948
ADMA Biologics
ADMA
$3.78B
| $1.83M | ﹤0.01% |
+472,300
| New | +$1.83M |
|
1949
eXp World Holdings
EXPI
$1.77B
| $1.83M | ﹤0.01% |
165,000
+4,500
| +3% | +$49.9K |
|
1950
Iovance Biotherapeutics
IOVA
$836M
| $1.83M | ﹤0.01% |
285,756
+6,200
| +2% | +$39.6K |
|